ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blueberry compound joins hormone therapy in fight against uterine cancer
Disease control OngoingThis study tests whether adding pterostilbene (an antioxidant from blueberries) to the hormone drug megestrol acetate works better than megestrol alone in treating endometrial cancer or precancerous changes. About 44 women scheduled for hysterectomy will receive the treatment bef…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Targeted therapy shows promise for Tough-to-Treat uterine cancer
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 50 people with endometrial cancer that has returned or not responded to chemotherapy. The drug works like a smart bomb, delivering chemotherapy directly to cancer cells. The main goal is to see if it can shrink tumors and he…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Cancer fear study pulled before starting
Knowledge-focused TerminatedThis study was designed to see if an online mental health program could help women with advanced gynecologic or breast cancer cope with the fear of their cancer coming back or getting worse. It planned to compare the program to standard educational materials. However, the study w…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC